GlassScriptPhysician profile
George M Galvan
NPI 1255512539
$82,643.44
in general payments reported to CMS, 2019-2025
30 companies · $28K in 2025
The $28K reported for 2025 was more than what 92% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $6,767 · 2021: $2,859 · 2022: $11K · 2023: $12K · 2024: $8,839 · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Consulting Fee: $14K · Food and Beverage: $12K · Travel and Lodging: $4,244 · Education: $664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,077.50 |
| Consulting Fee | $14,315.00 |
| Food and Beverage | $11,762.16 |
| Travel and Lodging | $4,243.88 |
| Education | $664.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $24,090.48 | 2019-2024 | Vyrsa V1, Senza |
| Abbott Laboratories | $22,184.64 | 2019-2025 | Proclaim, Eterna, Penta |
| Globus Medical, INC. | $13,617.09 | 2025 | Vyrsa V1, Senza, Vyrsa V1 |
| Biotronik Nro, INC. | $11,052.60 | 2024-2025 | Prospera |
| Medtronic, INC. | $3,142.99 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Mazor X System |
| Painteq LLC | $2,401.41 | 2023-2024 | Painteq |
| Si-Bone, INC. | $1,938.32 | 2019-2025 | |
| Boston Scientific Corporation | $819.30 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Medtronic USA, INC. | $762.84 | 2019-2020 | |
| Mission Medical Distribution, LLC | $434.52 | 2025 | |
| Providence Medical Technology, INC. | $306.95 | 2019-2025 | |
| Stimwave Technologies Incorporated | $284.75 | 2019 | |
| Baxter Healthcare | $239.60 | 2019-2023 | Floseal |
| Arthrex, INC. | $209.95 | 2025 | |
| Orthofix Medical, INC. | $191.42 | 2024-2025 | Spinal-Stim, Cervical-Stim |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 4web, INC. | $160.94 | 2025 | Spine Truss System |
| Cerapedics INC. | $136.61 | 2022 | |
| Novo Nordisk INC | $124.99 | 2023 | Wegovy |
| Kuros Biosciences USA, INC | $118.25 | 2024 | Magnetos |
| Biodelivery Sciences International, INC. | $107.23 | 2019 | |
| Spr Therapeutics, INC | $80.81 | 2024 | Sprint Pns System |
| Depuy Synthes Sales INC. | $65.66 | 2024 | Zero-P, Vivigen Mis Delivery System |
| Biotronik INC. | $40.51 | 2023-2025 | Prospera |
| Djo, LLC | $28.98 | 2021 | |
| Ethicon US, LLC | $25.51 | 2021 | |
| Bioventus LLC | $17.97 | 2022 | |
| Saluda Medical Americas, INC. | $16.72 | 2024 | Evoke |
| Vertiflex, INC. | $15.86 | 2019 | |
| Intrinsic Therapeutics | $15.71 | 2023 | Barricaid Acd (Annular Closure Device) |
| Zimmer Biomet Holdings, INC. | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Galvan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.